-Bloomberg TV
Neurocrine Biosciences Q4 Adjusted EPS $1.24 Beats $1.14 Estimate, Sales $412.00M Beat $409.09M Estimate
Neurocrine Biosciences (NASDAQ:NBIX) reported quarterly earnings of $1.24 per share which beat the analyst consensus estimate of $1.14 by 8.77 percent. This is a 3000 percent increase over earnings of $0.04 per share